Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The hospital-at-home technologies market was valued at USD 9.30 Billion in 2025 and is expected to reach USD 40.32 Billion by 2035, growing at a CAGR of 15.80%. Growth is driven by pressure on inpatient bed capacity, payer support for home episodes, wearable biosensor advances and the multi-year extension of the United States waiver.

Patent activity covers more than 7,380 families, led by wearable vital signs sensing, deterioration prediction and connected infusion, with filings peaking in 2021 and 2023. Validation comes from about 400 approved United States hospitals and from consolidation among operators such as DispatchHealth and Medically Home.

This Hospital-at-Home Technologies Patent Landscape Analysis Report maps assignees, jurisdictions and innovation clusters for sensing, analytics, infusion and orchestration technologies that deliver acute care in the home.

Executive Snapshot

  • Global hospital-at-home technologies market valued at USD 9.30 Billion in 2025
  • Market projected to reach USD 40.32 Billion by 2035
  • Expected CAGR of 15.80% during 2026-2035
  • Approximately 7,380+ patent families analysed across the landscape
  • 285+ hospital-at-home technologies patents were granted in 2025
  • Leading jurisdictions include the United States, China, and Europe
  • 2,970+ hospital-at-home technologies patents are associated with the United States
  • Major innovation areas include continuous wireless vital signs sensing, early warning and deterioration algorithms, connected home infusion systems, and remote care orchestration software
  • Top assignees include Philips, Medtronic, Masimo, GE HealthCare, and Baxter
  • The hospital-at-home technologies market is experiencing strong growth, driven by acute care bed capacity pressure, payer and Medicare waiver support, and advances in wearable biosensors. The United States waiver programme reached about 400 approved hospitals across more than 140 health systems by July 2025, and its extension to 2030 supports continued capital commitments in home sensing and software.

  • Patent activity is accelerating, with 285+ hospital-at-home technologies patents granted in 2025, reflecting strong innovation momentum in continuous wireless vital signs sensing, early warning and deterioration algorithms, connected home infusion systems, and remote care orchestration software.

  • Top assignees in the hospital-at-home technologies patent landscape include Philips, Medtronic, Masimo, GE HealthCare, and Baxter, with the United States, China, and Europe as the dominant patent jurisdictions.

Hospital-at-Home Technologies Market Size, Growth Trends, and Industry Outlook

Hospital-at-home technologies let health systems deliver acute, inpatient-level care in a patient's residence by combining wearable sensors, connected devices, clinical software and delivery logistics. Demand comes from hospitals with constrained bed capacity, payers seeking lower-cost episodes and patients who recover well in familiar surroundings. Adoption concentrates in conditions with predictable treatment paths, such as heart failure, pneumonia, cellulitis and exacerbations of chronic obstructive pulmonary disease.

The market growth is driven by the Acute Hospital Care at Home waiver in the United States, which had approved about 400 hospitals across more than 140 health systems by July 2025. The waiver lapsed briefly in late 2025 and was then extended through 30 September 2030, giving health systems a multi-year horizon for spending on sensors, hubs and software.

DispatchHealth and Medically Home announced a merger in March 2025 that spans 50 metropolitan areas and nearly 40 health systems, which shows operators consolidating logistics and clinical platforms to reach scale. A 2020 randomised trial in Annals of Internal Medicine reported 30-day readmissions of 7% for home patients against 23% for hospital patients, and this evidence continues to support payer coverage of home episodes. Every new programme needs sensing, escalation logic and supply coordination, so patent filings expand with enrolment.

Total Number of Patents for Hospital-at-Home Technologies

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Hospital-at-Home Technologies Patent Filing Trends and Innovation Activity

Patent filings in hospital-at-home technologies rose with each wave of programme enrolment after the November 2020 waiver launch. Applicants file first in the United States, where the waiver created the earliest reimbursable pathway, then in China and Europe.

The dataset identifies about 7,380 patent families, with filing peaks in 2021 and 2023 as wearable biosensor and care orchestration applications multiplied. Granted patents exceeded 285 in 2025, and roughly 2,970 patents are associated with the United States.

Each approved programme creates demand for sensors, escalation logic and in-home logistics, and that demand shows up as steady growth in family counts.

Scope of the Hospital-at-Home Technologies Patent Landscape Analysis Report

The study covers granted patents and published applications that protect technologies used to deliver acute, hospital-level care at a patient's residence. These include wireless vital signs sensors, deterioration scoring software, connected infusion systems, in-home diagnostics and clinical command-centre platforms.

General video visit software, home health staffing tools and bedside equipment designed for inpatient wards form the outer boundary. Such documents enter the dataset when their claims address a home acute care workflow.

Entities analysed include medical device manufacturers, consumer electronics groups, health information technology vendors, hospital systems, universities and specialised hospital-at-home operators.

The report will cover the following sections in detail:

Analysis by Technology

  • Wearable Biosensing
  • Deterioration Analytics
  • Infusion and Medication Systems
  • Orchestration Software
  • In-Home Diagnostics

Analysis by Clinical Application

  • Heart Failure Exacerbation
  • Respiratory and Pneumonia Care
  • Infection and Cellulitis Treatment
  • Post-Surgical Recovery
  • Oncology Supportive Care

Analysis by Device Type

  • Wearable Biosensors
  • Connected Infusion Pumps
  • Portable Diagnostic Devices
  • Patient Hubs and Tablets
  • Home Respiratory Devices

Global Hospital-at-Home Technologies Patent Landscape Analysis

Hospital-at-Home Technologies Patent Filing Trend Analysis

Patent filings grew at an estimated 14% per year between 2020 and 2024, led by remote sensing and software claims. The 2020 public health emergency and the CMS waiver introduced in November 2020 pulled forward investment in wearable monitoring and remote clinical workflows.

Growth since 2023 comes from cellular-connected hubs, machine learning models for early deterioration detection and infusion systems with remote clinician control. Health systems and operators now file from a small base as they protect care protocols and logistics inventions.

Leading Companies and Assignee Analysis in the Hospital-at-Home Technologies Patent Landscape

Among the players with hospital-at-home technologies patent families, new entrants have been identified, which can be either established companies or startups developing novel technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Philips

Philips holds one of the largest portfolios in connected patient monitoring, spanning IntelliVue bedside monitors, wearable biosensors and the eICU tele-critical-care programme. Its 2021 purchase of BioTelemetry added ambulatory cardiac monitoring and a remote service network that health systems reuse for home episodes. Patent families cluster around sensor-to-cloud data pipelines, patient deterioration scoring and tele-ICU workflows. Many of its monitoring devices carry FDA 510(k) clearance and CE marking, which lets one hardware family serve hospital and home settings. Philips sells under multi-year enterprise agreements and positions its monitoring stack as the sensing layer for virtual care. Its filing approach favours broad system claims backed by dense continuation families.

Medtronic

Medtronic builds its home-relevant portfolio on Nellcor pulse oximetry, Microstream capnography, BIS depth-of-anaesthesia monitoring and the LINQ II insertable cardiac monitor. Patent families protect sensor design, signal processing and algorithms that flag arrhythmia or respiratory compromise, with CareLink supplying remote data review. Most products hold FDA clearance or approval and CE marking, and several have long clinical track records in acute care. The company files continuation and divisional applications around legacy platforms, which keeps its sensing claims in force for many years. Commercial positioning centres on hospital procurement contracts, where Medtronic supplies sensors and monitors that health systems extend into home programmes.

Other companies include Masimo, GE HealthCare, and Baxter.

The top five assignees hold an estimated quarter of identified families, which leaves a long tail of start-ups, universities and health systems. Philips leads on patient monitoring and tele-critical-care families, and Medtronic is strong in pulse oximetry, capnography and implantable cardiac monitoring. Masimo has grown its share through wearable oximetry and medical watch filings.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Geographic Analysis of Hospital-at-Home Technologies Patent Activity

The report assesses patent activity across major jurisdictions, including:

  • United States
  • Europe
  • China
  • Japan
  • South Korea
  • India
  • International and WIPO filings

The United States leads filing volume because of the Medicare waiver and a large base of hospital programmes. China follows as home-based acute care pilots expand, and Europe ranks third, supported by virtual ward programmes in the United Kingdom, Germany and the Nordic countries.

Global Hospital-at-Home Technologies Patents - Country-wise Analysis for Key Players

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Hospital-at-Home Technologies Technology Segmentation and Innovation Areas

The report segments hospital-at-home technology patents into the following innovation areas:

  • Wireless wearable vital signs sensing
  • Early warning and deterioration algorithms
  • Connected infusion and medication management
  • Remote clinical orchestration and command-centre software
  • Mobile diagnostics and in-home point-of-care testing

Among these, wireless wearable vital signs sensing holds the largest share of patent families, since every approved programme depends on continuous physiological data.

Competitive Landscape and Emerging Trends in the Hospital-at-Home Technologies Market

Competition spans medical device groups, consumer electronics firms, software vendors and care operators. Philips, Medtronic and Masimo defend sensing hardware, and platform companies such as Current Health, DispatchHealth and Biofourmis protect workflow and analytics claims. Best Buy sold Current Health back to its co-founder in 2025, a sign that ownership of the home care technology stack is still shifting.

Companies are focusing on:

  • Continuous wearable biosensors for temperature, oxygen saturation and heart rhythm
  • Cellular and low-power connectivity hubs for patient homes
  • Deterioration prediction and escalation protocols
  • Remote-controlled infusion pumps and medication adherence systems
  • Portable ultrasound, blood analysis and imaging for home use
  • Clinical command centres and telepresence workflows
  • Supply chain, scheduling and mobile care team routing

Emerging innovation themes include multimodal deterioration models that merge wearable, camera and voice data, infusion pumps rated for home use, autonomous medication dispensing with remote pharmacist verification, and generative documentation for home visits. Applicants also file on interoperability gateways that stream home data into electronic health records.

Strategic Insights from the Hospital-at-Home Technologies Patent Landscape

The field combines regulated medical hardware with fast-moving software, so freedom-to-operate reviews need both device and software claim analysis. Hardware families from established monitoring companies stay in force for many years, while software families from operators and start-ups carry shorter commercial horizons. Health systems running programmes at scale are beginning to build their own filings.

Technology segments, assignee portfolios and jurisdictional trends are mapped in this report, which provides actionable intelligence supporting:

  • Intellectual property strategy
  • R&D prioritisation
  • Competitive benchmarking
  • Technology scouting
  • Licensing evaluation
  • Partnership assessment
  • Investment analysis
  • Market entry planning
  • Portfolio expansion strategy

Research Methodology for the Hospital-at-Home Technologies Patent Landscape Analysis

The study searched the USPTO, the European Patent Office, the China National Intellectual Property Administration, the Japan Patent Office, Espacenet and the WIPO PCT collection. Queries combined CPC and IPC classes such as A61B 5/00, G16H 40/67, G16H 80/00, A61M 5/142 and G08B 21/04 with keywords on home acute care, virtual wards and remote inpatient care.

Records were screened for relevance, deduplicated and consolidated at patent family level. Legal status, grant year, assignee and jurisdiction were normalised, and assignee names were merged across subsidiaries and acquired companies.

The market side draws on CMS and FDA documents, company disclosures, clinical trial registries and peer-reviewed literature, including randomised trials of acute home care. Patent counts are rounded approximations as of October 2026.

Related Reports

Smart Home Healthcare Market

AI in Remote Patient Monitoring Market

Prenatal Monitoring Devices Patent Landscape Analysis Report

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Frequently Asked Questions About This Report

EMR’s Hospital-at-Home Technologies Patent Landscape Analysis provides a comprehensive assessment of patent filings, innovation clusters, assignee portfolios, and geographic filing patterns across the hospital-at-home technologies landscape. The report identifies 7,380+ patent families, evaluates leading jurisdictions including the United States, China, and Europe, and profiles the top assignees by portfolio size.

The global hospital-at-home technologies market was valued at USD 9.30 Billion in 2025. The market is projected to reach USD 40.32 Billion by 2035, expanding at a CAGR of 15.80% during 2026 - 2035.

The report analyses approximately 7,380+ patent families related to hospital-at-home technologies. These include filings from the United States, China, Europe, and international WIPO filings.

Key companies operating within the landscape include Philips, Medtronic, Masimo, GE HealthCare, and Baxter, among others. These organisations collectively account for a significant portion of patent activity analysed in this report.

The report evaluates patent activity across the United States, Europe, China, Japan, South Korea, India, and international WIPO filings. The United States leads with roughly two-fifths of identified hospital-at-home technology patent families, followed by China and Europe.

Yes. The report scope can be customised based on geography, technology segment, assignee selection, time period, or specific innovation cluster focus. Please connect with the EMR team to define the customisation scope.

Patent landscape analysis helps organisations understand innovation trends, competitive activity, technology whitespace, and IP risk across a defined domain. For hospital-at-home technologies, this report supports strategic decisions in R&D prioritisation, licensing evaluation, competitive benchmarking, and market entry planning.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Scope of the Report

Details

Analysis by Technology

  • Wearable Biosensing
  • Deterioration Analytics
  • Infusion and Medication Systems
  • Orchestration Software
  • In-Home Diagnostics

Analysis by Clinical Application

  • Heart Failure Exacerbation
  • Respiratory and Pneumonia Care
  • Infection and Cellulitis Treatment
  • Post-Surgical Recovery
  • Oncology Supportive Care

Analysis by Device Type

  • Wearable Biosensors
  • Connected Infusion Pumps
  • Portable Diagnostic Devices
  • Patient Hubs and Tablets
  • Home Respiratory Devices

Analysis by End User

  • Hospitals and Health Systems
  • Home Health Agencies
  • Health Insurers and Payers
  • Post-Acute Care Providers
  • Accountable Care Organisations

Key Players Mentioned

  • Philips
  • Medtronic
  • Masimo
  • GE HealthCare
  • Baxter

Geographies Covered

  • North America
  • Europe
  • Asia Pacific
  • Others

Mini Report

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Mini Report

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us